LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q3 2025 Earnings Call Transcript November 5, 2025
LENZ Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.58513, expectations were $-0.67.
Operator: Good afternoon, ladies and gentlemen, and welcome to the LENZ Therapeutic Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. At this time, I’d like to turn the call over to Dan Chevallard, Chief Financial Officer. Please...
